Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
Elacestrant is used to treat estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR-1 mutated, advanced or metastatic (cancer that has spread) breast cancer that has progressed after receiving endocrine treatment in men or in women who have already stopped menstruating (postmenopausal). Your doctor will test for the presence of the mutation.
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: